Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990;100(3):372-6.
doi: 10.1007/BF02244609.

5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats

Affiliations

5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats

F Jenck et al. Psychopharmacology (Berl). 1990.

Abstract

The functional role of brain 5-HT and 5-HT receptor subtypes in periaqueductal gray (PAG) induced aversion has been investigated in rats. Antiaversive effects were found with the serotonin agonists TFMPP, mCPP and DOI but not with RU 24969 which was found to facilitate PAG aversion. The first three serotonin agonists share potent 5-HT1C activity while RU 24969 differs with a high 5-HT1A activity. Proaversive effects were found with the mixed 5-HT1C/5-HT2 antagonists cyproheptadine and ritanserin; this effect was already reported for the mixed 5-HT1C/5-HT2 antagonists metergoline and mianserin and is opposite to the effects of the selective 5-HT2 antagonists ketanserin, pirenperone, trazodone and spiperone. The antiaversive effects of mCPP (1 mg/kg) could be prevented by pretreatment of the animals with mianserin (1 and 10 mg/kg). These results suggest that 5-HT1C receptors play an important role in the serotonergic control of PAG aversion. 5-HT1C receptor activation seems to mediate antiaversive effects whereas acute 5-HT1C receptor blockade appears to facilitate PAG aversion. Functional interactions take place between several receptor types in the in vivo control of PAG aversion, where 5-HT1C receptors appear to play a predominant function.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brain Res. 1982 Sep 30;248(2):313-20 - PubMed
    1. Br J Pharmacol. 1987 Aug;91(4):747-52 - PubMed
    1. Eur J Pharmacol. 1989 Feb 28;161(2-3):219-21 - PubMed
    1. Br J Pharmacol. 1988 May;94(1):137-47 - PubMed
    1. Pharmacol Biochem Behav. 1978 Sep;9(3):287-95 - PubMed

LinkOut - more resources